certainty lives in layersphilips.taimaz.com/wp-content/uploads/2018/06/philips... · 2018. 6....
TRANSCRIPT
Certainty lives in layers
Philips IQon Spectral CT
Overcoming these challenges with imagingFacilities are being driven by reimbursement streams to ask the following questions:
Certainty lives in layers
As standardized quality measures
place an increased importance
on diagnostic certainty, the need
for solutions that produce more
definitive and accurate data than
conventional CT technology has
become apparent.
And that’s where detector-based
spectral technology comes in.
As the world’s first spectral
detector-based CT, the Philips
IQon Spectral CT delivers
multiple layers of retrospective
data in a single, low-dose scan,
empowering you to improve
clinical confidence that may
impact your quality outcomes.
With the IQon Spectral CT:
The first exam is the right exam.
You’ll have answers for your most challenging cases.
The advances are powerful—the workflow stays the same.
• Can we increase diagnostic accuracy
without increased dosage?
• How do we improve efficiency and
reduce errors?
• What can we do to fully integrate
evidence-based imaging practices?
• How can we better adhere to clinical
pathway protocols?
• Can we improve upon our approach
to patient-centric care and service
excellence for the department and
health system?
A new landscape with new challengesThe world of healthcare is shifting to a patient-centric, payment-for-services model—driving leaders in our field to ask: How can we provide better patient experiences* and improve clinical outcomes while achieving the economic objectives of our organization?
Conventional CT scans often produce ambiguous or inaccurate data that can require additional testing. To provide better patient experiences* and empower you to improve clinical outcomes while achieving the economic objectives of your organization, there’s a clear advantage to making the right diagnosis in the first scan. The first
exam is the right exam
• Reduce time and costs by
decreasing the number of
patient findings that are
indeterminate, providing
the opportunity to positively
impact patient care
• Reduce workflow complexity
• Reduce the need for additional tests through the
ability to create angiograms
from routine or low injected
contrast volume studies
• Transform a sub-optimal CTA exam into an optimal
diagnostic CTA
By delivering spectral results 100% of the time in a single scan, the Philips IQon Spectral CT can:
Case study
Is that a lesion?
Could be.
Could be nothing.
I can’t solve what I can’t see.
I need to be certain.
This conventional CT image shows what could be a suspicious area in the liver. However, further enhancement was needed to
better visualize the possible lesion. Normally, this patient would require additional scanning, such as MR or ultrasound.
*AAPM Technical Report 96 INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
This patient, who was previously diagnosed with hepatic cell carcinoma and liver cirrhosis, underwent ablation to treat the hepatic lesions. Ablation effectiveness following treatment was a concern. The following images were taken on the Philips IQon Spectral CT.
Scan Data: CTDIvol: 15.2 mGyDLP: 550mGyxcmEffective Dose: 8.2mSv (k=0.015)*
Images courtesy of University of Texas Southwestern Medical Center
*AAPM Technical Report 96 INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
Spectral Monoenergetic (MonoE) Image
This 45 keV MonoE image reveals visualization of a suspected lesion. An additional scan is not needed to confirm.
Case study
This patient, who was previously diagnosed with hepatic cell carcinoma and liver cirrhosis, underwent ablation to treat the hepatic lesions. Ablation effectiveness following treatment was a concern. The following images were taken on the Philips IQon Spectral CT.
Scan Data: CTDIvol: 15.2 mGyDLP: 550mGyxcmEffective Dose: 8.2mSv (k=0.015)*
Images courtesy of University of Texas Southwestern Medical Center
*AAPM Technical Report 96 INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
Case Study
Z Effective Spectral Results
Here, we can visualize iodine uptake, adding another layer of information. Because spectral information is always on with the IQon Spectral CT, this additional information is available whenever a deeper analysis is needed.
This patient, who was previously diagnosed with hepatic cell carcinoma and liver cirrhosis, underwent ablation to treat the hepatic lesions. Ablation effectiveness following treatment was a concern. The following images were taken on the Philips IQon Spectral CT.
Scan Data: CTDIvol: 15.2 mGyDLP: 550mGyxcmEffective Dose: 8.2mSv (k=0.015)*
Images courtesy of University of Texas Southwestern Medical Center
*AAPM Technical Report 96 INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
This patient, who was previously diagnosed with hepatic cell carcinoma and liver cirrhosis, underwent ablation to treat the hepatic lesions. Ablation effectiveness following treatment was a concern. The following images were taken on the Philips IQon Spectral CT.
Scan Data: CTDIvol: 15.2 mGyDLP: 550mGyxcmEffective Dose: 8.2mSv (k=0.015)*
Images courtesy of University of Texas Southwestern Medical Center
The Philips IQon Spectral CT was
able to take a conventional CT and
lower the MonoE to provide layers
of spectral results in one scan.
With the IQon Spectral CT,
certainty lives in layers.
Z Effective Spectral Results
Conventional CT Spectral Monoenergetic Image
Case study
Is that normal cardiac anatomy?
Or lack of blood flow?
There’s no room for guesswork
when it comes to AFib.
How can I be sure?
Conventional [HU]This conventional CT image shows a left atrial hypoattenuating
lesion; whether it’s thrombus or slow flow cannot be determined. This would ordinarily require additional testing and delays.
Case study
INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
A 53-year old patient was being evaluated for pulmonary venous anatomy prior to radiofrequency ablation for atrial fibrillation and was referred to CT following an abnormal Transesophageal Echocardiogram (TEE).
Scan Data: CTDIvol: 12.1 mGykVp: 120mAs: 87Scan length: 23.2 cm
Images courtesy of University Hospitals Case Medical Center
INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
Spectral Monoenergetic (MonoE) Image
The 45 keV MonoE image shows iodine enhancement in the coronary anatomy, but still leaves a questionable distinction between thrombus or slow flow. Additional spectral results are needed.
MonoE 45keV[HU]
Case study
A 53-year old patient was being evaluated for pulmonary venous anatomy prior to radiofrequency ablation for atrial fibrillation and was referred to CT following an abnormal Transesophageal Echocardiogram (TEE).
Scan Data: CTDIvol: 12.1 mGykVp: 120mAs: 87Scan length: 23.2 cm
Images courtesy of University Hospitals Case Medical Center
INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
Iodine Overlay
The Iodine Overlay image shows absence of iodine in the lesion. Absence of iodine typically indicates a thrombus rather than slow flow.
Conventional [HU]Overlay: Iodine Density [mg/ml]
Case study
A 53-year old patient was being evaluated for pulmonary venous anatomy prior to radiofrequency ablation for atrial fibrillation and was referred to CT following an abnormal Transesophageal Echocardiogram (TEE).
Scan Data: CTDIvol: 12.1 mGykVp: 120mAs: 87Scan length: 23.2 cm
Images courtesy of University Hospitals Case Medical Center
INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
Characterizing the presence of a
left atrial lesion and confirming
the presence of a thrombus
rather than slow flow allowed the
medical team to more confidently
formulate a treatment plan.
With the IQon Spectral CT,
certainty lives in layers.
Iodine Overlay Image
Conventional CT Spectral Monoenergetic Image
A 53-year old patient was being evaluated for pulmonary venous anatomy prior to radiofrequency ablation for atrial fibrillation and was referred to CT following an abnormal Transesophageal Echocardiogram (TEE).
Scan Data: CTDIvol: 12.1 mGykVp: 120mAs: 87Scan length: 23.2 cm
Images courtesy of University Hospitals Case Medical Center
Case study
The answer for your most challenging cases
• Uncover obscured pathology
though improved visualization
and assessment of tissue in
proximity to metal implants
• Reduce radiation dose
through the full use of
iterative reconstruction
techniques (IMR) and dose
management tools including
3D dose modulation
• Determine therapy response through contrast
enhancement in lesions
• Experience enhanced diagnostic capabilities, even
in patients who would not
have been preselected for
dual-energy techniques
The Philips IQon Spectral CT helps you extend the benefits of spectral data to all patients, providing answers for even the most challenging scenarios. Being able to achieve diagnostic confidence, in even the most problematic situation, can help you provide better patient experiences* and improve clinical care.
With improved tissue characterization and visualization, and full use of dose management tools, the Philips IQon Spectral CT allows you to:
A challenging case can cause a great deal of uncertainty for the physician searching for the correct diagnosis and treatment plan.
An 85-year-old patient with aortic valve stenosis and dyspnea needed scans for a pre-procedural evaluation. Because of his challenging condition, he could only tolerate 20 cc of injected contrast which, in a conventional CT, yields poor visualization of the vasculature.
Scan Data: CTDIvol: 14.6 mGykVp: 120mAs: 154Scan length: 40.0 cm
Images courtesy of University Hospitals Case Medical Center.
We need to do a pre-surgical plan for aortic valve replacement (TAVR).
But the patient can’t tolerate the routine
volume of IV contrast.
How do I visualize vascular access?
Case study
INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
Spectral Monoenergetic (MonoE) Image
Even with 20 cc of injected contrast, lowering the MonoE to 45 keV enhanced iodine visualization in the aorta.
Case study
An 85-year-old patient with aortic valve stenosis and dyspnea needed scans for a pre-procedural evaluation. Because of his challenging condition, he could only tolerate 20 cc of injected contrast which, in a conventional CT, yields poor visualization of the vasculature.
Scan Data: CTDIvol: 14.6 mGykVp: 120mAs: 154Scan length: 40.0 cm
Images courtesy of University Hospitals Case Medical Center.
INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
Spectral Advanced Vessel Analysis
Using Spectral Advanced Vessel Analysis enabled measurement of the vessel diameter for catheter placement. This allowed for visualization of the iliac artery for planning and access to the aortic valve.
Case study
An 85-year-old patient with aortic valve stenosis and dyspnea needed scans for a pre-procedural evaluation. Because of his challenging condition, he could only tolerate 20 cc of injected contrast which, in a conventional CT, yields poor visualization of the vasculature.
Scan Data: CTDIvol: 14.6 mGykVp: 120mAs: 154Scan length: 40.0 cm
Images courtesy of University Hospitals Case Medical Center.
INVESTIGATIONAL DEVICE, LIMITED BY UNITED
STATES LAW TO INVESTIGATIONAL USE.
Vascular procedures on certain patient
populations can be very challenging.
The medical team was able to plan a
vascular procedure on this challenging
patient.
With the IQon Spectral CT, certainty
lives in layers.
Spectral Monoenergetic Image
Spectral Advanced Vessel Analysis
Conventional CT
Case study
An 85-year-old patient with aortic valve stenosis and dyspnea needed scans for a pre-procedural evaluation. Because of his challenging condition, he could only tolerate 20 cc of injected contrast which, in a conventional CT, yields poor visualization of the vasculature.
Scan Data: CTDIvol: 14.6 mGykVp: 120mAs: 154Scan length: 40.0 cm
Images courtesy of University Hospitals Case Medical Center.
• Acquire spectral results
as part of a routine CT
scan
• Review and analyze spectral data on PACS,
with results ready in five
minutes
• Integrate spectral solutions easily, because
spectral is always on, 24/7
• Use spectral data to
address a wide variety of
complex clinical questions
• Analyze spectral results
retrospectively from
anywhere within your
enterprise
The Philips IQon Spectral CT and the Spectral Diagnostic Suite easily and fully integrates into your current workflow, allowing you to:
Training multiple professionals on a new system all at once can be a challenge. There’s a large variability in speed and skill level in learning and adjusting to new technologies.
The advancements are powerful–the workflow is the same
spectral results 100% of the time
within 5 minutes
always on 24/7
viewable from anywhere in organization
Now, every
technician can
acquire spectral data with
every scan—data that can be
viewed by physicians and care
teams across your organization to
help determine the best path for
patient care.
Spectral Diagnostic SuiteA suite of advanced visualization applications for the Philips IQon Spectral CT, the Spectral Diagnostic Suite delivers advanced spectral and clinical application tools, including Spectral Magic Glass and the Spectral Magic Glass on PACS app.
Philips helps you get the most out of your customer service Philips has developed service innovations designed to reduce time of repair and support an evolution towards fully predictive maintenance.
Low-dose solutions delivering on quality measures With the Philips IQon Spectral CT, you’ll have the full use of dose management tools—like iterative model reconstruction (IMR) and 3D dose modulation—allowing you to experience all the benefits of spectral data at the same dose levels as a conventional CT scan.
Spectral Magic GlassIn addition to conventional CT
images, Philips Spectral Magic
Glass enables on-demand
simultaneous viewing and quick
comparison of up to five different
spectral results for a region of
interest, including Monoenergetic,
Iodine Density, Virtual Non-
contrast, Iodine no Water, and Z
Effective maps.
Spectral Magic Glass on PACS appThe Spectral Magic Glass on PACS
app conveniently launches directly
in the user’s PACS viewing setup.
Spectral Magic Glass on PACS
is only available with the IQon
Spectral CT and offers a simple
interface that integrates into your
organization’s current workflow with
little or no training.
Integrated Health System monitoringPredictive maintenance
that leverages
information from
more than 400 health
properties and over
3,000 data points
Onboard visual diagnosticsAdvanced auto-
diagnostic routines
that offer faster failure
identification and
resolution
Expanded remote capabilitiesAutomated data
collection and expanded
diagnostic routines
that can be executed
remotely for real-time
clinical support
Proactive remote monitoringRemote teams of
global experts who
collaborate with local
service and your staff to
monitor performance,
detect anomalies, and
immediately repair or
maintain your system
without interrupting
patient care
Spectral Magic Glass on PACS app is integrated with IntelliSpace PACS (iSite) and Sectra. In addition, we have completed ISP (SpDS) integration on several PACS and can make available upon request our open interface document to local hospital or PACS vendor IT in order to complete the Standard Integration.
When it comes to the positive
effects it can have on your
organization, that’s only the
beginning.
Because what the IQon Spectral CT
really delivers is certainty. With
certainty come solutions. And as
the world of healthcare advances
towards a patient-centric model,
those solutions can allow your
organization to provide better
patient experiences,* enhance
clinical care, and achieve
your economic objectives.
With the Philips IQon Spectral CT:• The first exam is the right
exam.
• You’ll have the answer for your most challenging cases.
• Though the advancements are powerful—the workflow is the same.
Sources:
Evaluating Optimal Monochromatic Energy Reconstruction on Aortic Angiography Obtained from Spectral Detector CT
Prabhakar Rajiah MD, FRCR (Presenter): Institutional Research Grant, Koninklijke Philips NV, Andrew Sher MD: Research Grant, Koninklijke Philips NV, Abed Ghandour MD :
Nothing to Disclose, Rong Rong MD: Institutional Grant support, Koninklijke Philips NV, Amar Dhanantwari: Employee, Koninklijke Philips NV
Fleischmann,D, Vascular Imaging Series: CT Angiography-New Techniques and Their Application. Radiological Society of North America 2014 Scientific Assembly and Annual
Meeting, November 30 - December 5, 2014, Chicago IL
Incremental Benefit and Clinical Significance of Retrospectively Obtained Spectral Data in a Novel Spectral Detector CT Technology- Initial Experiences and Results
Claudia M. Martinez Rios Arellano MD: Research Grant, Koninklijke Philips NV, Rong Rong MD: Institutional Grant support, Koninklijke Philips NV, Robert C. Gilkeson MD:
Research Consultant, Riverain
To learn more, please visit www.Philips.com/IQon
Images courtesy of University Hospitals Case Medical Center.
*The Centers for Medicare & Medicaid Services requires United States hospitals that treat Medicare patients to participate in the national Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey, a standardized tool that measures patients’ experience of hospital care. Results collected for public reporting are available at medicare.gov/hospitalcompare. The images and descriptions contained herein provide technical specifications and optional features which may not be included with the standard system configuration. Contact your local Philips Representative for complete specific system details. Some or all of the products, features, and accessories shown or described herein may not be available in your market. Please contact your local Philips Representative for availability.
© 2016 Koninklijke Philips N.V. All rights reserved. Specifications are subject to change without notice. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. www.philips.com